Standard BioTools Inc.
US ˙ NasdaqGS ˙ US34385P1084

SecurityLAB / Standard BioTools Inc.
InstitutionBellwether Advisors, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Bellwether Advisors, LLC closes position in LAB / Standard BioTools Inc.

On November 12, 2025 - Bellwether Advisors, LLC filed a 13F-HR form disclosing ownership of 0 shares of Standard BioTools Inc. (US:LAB) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 11, 2025 disclosing 2,016 shares of Standard BioTools Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-12 2025-09-30 13F STANDARD BIOTOOLS COM 34385P108 0 -2,016 -100.00 0 -100.00
2025-08-11 2025-06-30 13F STANDARD BIOTOOLS COM 34385P108 2,016 0 0.00 2 0.00 0.0004
2025-05-07 2025-03-31 13F STANDARD BIOTOOLS COM 34385P108 2,016 0 0.00 2 -33.33 0.0005
2025-02-14 2024-12-31 13F STANDARD BIOTOOLS COM 34385P108 2,016 2,016 4 0.0006
2023-08-04 2023-06-30 13F STANDARD BIOTOOLS INC COM Stock 34385P108 0 -2,016 -100.00 0 -100.00
2023-05-05 2023-03-31 13F STANDARD BIOTOOLS INC COM Stock 34385P108 2,016 0 0.00 4 50.00 0.0011
2023-02-13 2022-12-31 13F STANDARD BIOTOOLS INC COM Stock 34385P108 2,016 0 0.00 2 0.00 0.0007
2022-11-14 2022-09-30 13F STANDARD BIOTOOLS INC COM Stock 34385P108 2,016 0 0.00 2 -33.33 0.0007
2022-08-05 2022-06-30 13F STANDARD BIOTOOLS INC COM Stock 34385P108 2,016 0 0.00 3 -57.14 0.0010
2022-04-29 2022-03-31 13F STANDARD BIOTOOLS INC COM Stock 34385P108 2,016 0 0.00 7 0.00 0.0021
2022-01-28 2021-12-31 13F FLUIDIGM CORP DEL COM Stock 34385P108 2,016 0 0.00 7 -46.15 0.0022
2021-11-12 2021-09-30 13F FLUIDIGM CORP DEL COM Stock 34385P108 2,016 0 0.00 13 8.33 0.0043
2021-08-10 2021-06-30 13F FLUIDIGM CORP DEL COM Stock 34385P108 2,016 0 0.00 12 33.33 0.0041
2021-05-06 2021-03-31 13F FLUIDIGM CORP DEL COM Stock 34385P108 2,016 0 0.00 9 -25.00 0.0036
2021-01-29 2020-12-31 13F FLUIDIGM CORP DEL COM Stock 34385P108 2,016 2,016 12 0.0053
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.